At the time of writing, Hims & Hers Health Inc [HIMS] stock is trading at $57.56, up 4.18%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The HIMS shares have gain 7.37% over the last week, with a monthly amount glided 4.26%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Hims & Hers Health Inc [NYSE: HIMS] stock has seen the most recent analyst activity on June 04, 2025, when Needham reiterated its Buy rating and also boosted its price target to $65 from $61. Previously, TD Cowen downgraded its rating to Hold on April 29, 2025, and kept the price target unchanged to $30. On February 18, 2025, downgrade downgraded it’s rating to Equal-Weight and revised its price target to $60 on the stock. Citigroup downgraded its rating to a Sell and increased its price target to $25 on January 10, 2025. BTIG Research initiated its recommendation with a Buy and recommended $35 as its price target on January 07, 2025. Morgan Stanley started tracking with a Overweight rating for this stock on December 17, 2024, and assigned it a price target of $42. In a note dated November 14, 2024, BofA Securities downgraded an Underperform rating on this stock.
For the past year, the stock price of Hims & Hers Health Inc fluctuated between $13.47 and $72.98. Currently, Wall Street analysts expect the stock to reach $66.5 within the next 12 months. Hims & Hers Health Inc [NYSE: HIMS] shares were valued at $57.56 at the most recent close of the market. An investor can expect a potential return of 15.53% based on the average HIMS price forecast.
Analyzing the HIMS fundamentals
According to Hims & Hers Health Inc [NYSE:HIMS], the company’s sales were 1.78B for trailing twelve months, which represents an 110.67% jump. Gross Profit Margin for this corporation currently stands at 0.77% with Operating Profit Margin at 0.06%, Pretax Profit Margin comes in at 0.07%, and Net Profit Margin reading is 0.09%. To continue investigating profitability, this company’s Return on Assets is posted at 0.18, Equity is 0.36 and Total Capital is 0.18. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.12.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 54.88 points at the first support level, and at 52.20 for the second support level. However, for the 1st resistance point, the stock is sitting at 58.99, and for the 2nd resistance point, it is at 60.42.
Ratios To Look Out For
It is important to note that Hims & Hers Health Inc [NYSE:HIMS] has a current ratio of 1.59. As well, the Quick Ratio is 1.32, while the Cash Ratio is 0.98. Considering the valuation of this stock, the price to sales ratio is 7.22, the price to book ratio is 23.43 and price to earnings (TTM) ratio is 83.78.
Transactions by insiders
Recent insider trading involved Chi Michael, Chief Commercial Officer, that happened on Jun 10 ’25 when 5600.0 shares were sold. Officer, Chi Michael completed a deal on Jun 10 ’25 to buy 5400.0 shares. Meanwhile, Chief Commercial Officer Chi Michael sold 5100.0 shares on Jun 06 ’25.
